MatchaDB

2025Thèse ou mémoireAccès libre

Comparative bioactivity analysis of green and dark teas via metabolomics and in-silico modelling

Auteurs non indiqués

UpSpace Institutional Repository (University of Pretoria)

Texte intégral gratuit→

Résumé

Green and dark teas are rich in bioactive compounds with potential therapeutic effects in the management of type 2 diabetes mellitus (T2DM). This study aimed to comprehensively evaluate the antidiabetic potential of green and dark teas through an integrated experimental and computational workflow, incorporating metabolomics, enzyme inhibition assays, antioxidant assays, liver cell-based assays, and molecular modelling. A total of 24 commercially available tea samples, green, dark, black, matcha, and rooibos were sourced, and these teas were subjected to untargeted liquid chromatography-mass spectrometry (LC/MS) based metabolomics in negative ion mode to characterise their chemical compositions. Matcha tea served as a positive control due to its well-documented bioactivity, while rooibos served as a negative control since it is derived from a botanically unrelated plant. Black tea was included to differentiate metabolites arising from microbial fermentation in dark tea versus those generated via enzyme oxidation found in black tea. Metabolomic profiling revealed that green and dark teas share a core set of polyphenolic compounds, including epigallocatechin gallate (EGCG), epicatechin gallate (ECG), and gallic acid. Each tea exhibited unique signatures linked to fermentation and processing. Dark teas also contained additional fermentation-related metabolites such as ellagic acid derivatives and esculetin. Enzyme inhibition assays showed that green tea exhibited the strongest inhibition of both α-glucosidase (IC₅₀ = 20.09 ± 3.22 µg/mL) and α-amylase (IC₅₀ = 1.59 ± 0.11 mg/mL), showing significantly greater activity than the other teas (α < 0.001). Matcha and black teas displayed moderate inhibition (α > 0.05 between them), while dark tea showed weaker activity (IC₅₀ =…

Résumé raccourci. Lire le résumé complet à la source.

Le texte du résumé provient de PubMed, OpenAlex ou Europe PMC et appartient aux auteurs et à l'éditeur.

Type d'étude

Essai contrôlé randomisé

Les participants ont été répartis au hasard entre le matcha et un comparateur.

Attribué automatiquement à partir du titre, du résumé et des termes de sujet.

Thèmes

Le matcha est ici un sujet principal (nommé dans les mots-clés).

Mots-clés et termes de sujet

Votre dossier de recherche

Citer cette étude

(2025). Comparative bioactivity analysis of green and dark teas via metabolomics and in-silico modelling. UpSpace Institutional Repository (University of Pretoria).

Plus sur Métabolisme et poids

2023Article de revue

Monitoring chlorophyll changes during Tencha processing using portable near-infrared spectroscopy.

Liu L, Zareef M, Wang Z, et al. — Food chemistry

Monitoring chlorophyll during Tencha (the raw ingredient for matcha) processing is critical for determining the matcha's color and quality. The purpose of this study is to explore the mechanism of chlorophyll changes during Tencha…

Chimie / analyseCulture et ombrageTransformation, mouture et qualitéAuthenticité et méthodes d'analyseCité 106 fois
2018Article de revueAccès libre

Matcha green tea (MGT) inhibits the propagation of cancer stem cells (CSCs), by targeting mitochondrial metabolism, glycolysis and multiple cell signalling pathways.

Bonuccelli G, Sotgia F, Lisanti MP — Aging

Matcha green tea (MGT) is a natural product that is currently used as a dietary supplement and may have significant anti-cancer properties. However, the molecular mechanism(s) underpinning its potential health benefits remain largely…

In vitro / étude cellulaireMétabolisme et poidsAntioxydants et polyphénolsCancerCité 75 fois
2020Article de revue

Changes in Intestinal Microbiota of Type 2 Diabetes in Mice in Response to Dietary Supplementation With Instant Tea or Matcha.

Zhang HH, Liu J, Lv YJ, et al. — Canadian journal of diabetes

Objective: Gut microbiota plays a key role in metabolism and health in diabetes patients with gastrointestinal microbiota dysbiosis. Thus, regulating the ecological balance of gut microbiota may provide a pathway toward improvement for…

Étude animaleMétabolisme et poidsIntestin et microbiomeMarché, culture et durabilitéCité 74 fois

Parcourir toute la bibliothèque→